Global Mumps Vaccine Report Thumbnail

Global Mumps Vaccine Market by Age Group (Adult, Pediatric), by Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, Drug Stores) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: PH-76359
  • Author: Up Market Research
  • Rating: 4.8
  • Total Reviews: 75
  • No. Of Pages: 241
  • Format:
  • Pub. Date: 2022-01-14
  • Share:

Up Market Research published a new report titled “Mumps Vaccine Market research report which is segmented by Age Group (Adult, Pediatric), by Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, Drug Stores), By Players/Companies Merck & Co. Inc., MedImmune, Astellas Pharma India Private Limited, Sanofi, Emergent BioSolutions Inc., GlaxoSmithKline plc., Bavarian Nordic, Johnson & Johnson Private Limited, Serum Institute of India Pvt. Ltd., CSL Limited”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

Report AttributesReport Details
Report TitleMumps Vaccine Market Research Report
By Age GroupAdult, Pediatric
By Distribution ChannelRetail Pharmacies, Hospitals Pharmacies, Drug Stores
By CompaniesMerck & Co. Inc., MedImmune, Astellas Pharma India Private Limited, Sanofi, Emergent BioSolutions Inc., GlaxoSmithKline plc., Bavarian Nordic, Johnson & Johnson Private Limited, Serum Institute of India Pvt. Ltd., CSL Limited
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages241
Number of Tables & Figures169
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Mumps Vaccine Industry Outlook

Global Mumps Vaccine Market Report Segments:

The market is segmented by Age Group (Adult, Pediatric), by Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, Drug Stores).

Mumps Vaccine Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Mumps Vaccine Market

Overview of the regional outlook of the Mumps Vaccine Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Mumps Vaccine Market Overview

Highlights of The Mumps Vaccine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Mumps Vaccine Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
        6. By Age Group:

                1. Adult

                2. Pediatric

        7. By Distribution Channel:

                1. Retail Pharmacies

                2. Hospitals Pharmacies

                3. Drug Stores

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Mumps Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Mumps Vaccine Market Trends

Reasons to Purchase the Mumps Vaccine Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mumps Vaccine Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Mumps Vaccine Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Mumps Vaccine Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Mumps Vaccine Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Mumps Vaccine Market Size & Forecast, 2018-2028 
      4.5.1 Mumps Vaccine Market Size and Y-o-Y Growth 
      4.5.2 Mumps Vaccine Market Absolute $ Opportunity 

Chapter 5 Global Mumps Vaccine Market Analysis and Forecast by Age Group
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Age Group
      5.1.2 Basis Point Share (BPS) Analysis by Age Group
      5.1.3 Absolute $ Opportunity Assessment by Age Group
   5.2 Mumps Vaccine Market Size Forecast by Age Group
      5.2.1 Adult
      5.2.2 Pediatric
   5.3 Market Attractiveness Analysis by Age Group

Chapter 6 Global Mumps Vaccine Market Analysis and Forecast by Distribution Channel
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Distribution Channel
      6.1.2 Basis Point Share (BPS) Analysis by Distribution Channel
      6.1.3 Absolute $ Opportunity Assessment by Distribution Channel
   6.2 Mumps Vaccine Market Size Forecast by Distribution Channel
      6.2.1 Retail Pharmacies
      6.2.2 Hospitals Pharmacies
      6.2.3 Drug Stores
   6.3 Market Attractiveness Analysis by Distribution Channel

Chapter 7 Global Mumps Vaccine Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Mumps Vaccine Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Mumps Vaccine Analysis and Forecast
   9.1 Introduction
   9.2 North America Mumps Vaccine Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Mumps Vaccine Market Size Forecast by Age Group
      9.6.1 Adult
      9.6.2 Pediatric
   9.7 Basis Point Share (BPS) Analysis by Age Group 
   9.8 Absolute $ Opportunity Assessment by Age Group 
   9.9 Market Attractiveness Analysis by Age Group
   9.10 North America Mumps Vaccine Market Size Forecast by Distribution Channel
      9.10.1 Retail Pharmacies
      9.10.2 Hospitals Pharmacies
      9.10.3 Drug Stores
   9.11 Basis Point Share (BPS) Analysis by Distribution Channel 
   9.12 Absolute $ Opportunity Assessment by Distribution Channel 
   9.13 Market Attractiveness Analysis by Distribution Channel

Chapter 10 Europe Mumps Vaccine Analysis and Forecast
   10.1 Introduction
   10.2 Europe Mumps Vaccine Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Mumps Vaccine Market Size Forecast by Age Group
      10.6.1 Adult
      10.6.2 Pediatric
   10.7 Basis Point Share (BPS) Analysis by Age Group 
   10.8 Absolute $ Opportunity Assessment by Age Group 
   10.9 Market Attractiveness Analysis by Age Group
   10.10 Europe Mumps Vaccine Market Size Forecast by Distribution Channel
      10.10.1 Retail Pharmacies
      10.10.2 Hospitals Pharmacies
      10.10.3 Drug Stores
   10.11 Basis Point Share (BPS) Analysis by Distribution Channel 
   10.12 Absolute $ Opportunity Assessment by Distribution Channel 
   10.13 Market Attractiveness Analysis by Distribution Channel

Chapter 11 Asia Pacific Mumps Vaccine Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Mumps Vaccine Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Mumps Vaccine Market Size Forecast by Age Group
      11.6.1 Adult
      11.6.2 Pediatric
   11.7 Basis Point Share (BPS) Analysis by Age Group 
   11.8 Absolute $ Opportunity Assessment by Age Group 
   11.9 Market Attractiveness Analysis by Age Group
   11.10 Asia Pacific Mumps Vaccine Market Size Forecast by Distribution Channel
      11.10.1 Retail Pharmacies
      11.10.2 Hospitals Pharmacies
      11.10.3 Drug Stores
   11.11 Basis Point Share (BPS) Analysis by Distribution Channel 
   11.12 Absolute $ Opportunity Assessment by Distribution Channel 
   11.13 Market Attractiveness Analysis by Distribution Channel

Chapter 12 Latin America Mumps Vaccine Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Mumps Vaccine Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Mumps Vaccine Market Size Forecast by Age Group
      12.6.1 Adult
      12.6.2 Pediatric
   12.7 Basis Point Share (BPS) Analysis by Age Group 
   12.8 Absolute $ Opportunity Assessment by Age Group 
   12.9 Market Attractiveness Analysis by Age Group
   12.10 Latin America Mumps Vaccine Market Size Forecast by Distribution Channel
      12.10.1 Retail Pharmacies
      12.10.2 Hospitals Pharmacies
      12.10.3 Drug Stores
   12.11 Basis Point Share (BPS) Analysis by Distribution Channel 
   12.12 Absolute $ Opportunity Assessment by Distribution Channel 
   12.13 Market Attractiveness Analysis by Distribution Channel

Chapter 13 Middle East & Africa (MEA) Mumps Vaccine Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Mumps Vaccine Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Mumps Vaccine Market Size Forecast by Age Group
      13.6.1 Adult
      13.6.2 Pediatric
   13.7 Basis Point Share (BPS) Analysis by Age Group 
   13.8 Absolute $ Opportunity Assessment by Age Group 
   13.9 Market Attractiveness Analysis by Age Group
   13.10 Middle East & Africa (MEA) Mumps Vaccine Market Size Forecast by Distribution Channel
      13.10.1 Retail Pharmacies
      13.10.2 Hospitals Pharmacies
      13.10.3 Drug Stores
   13.11 Basis Point Share (BPS) Analysis by Distribution Channel 
   13.12 Absolute $ Opportunity Assessment by Distribution Channel 
   13.13 Market Attractiveness Analysis by Distribution Channel

Chapter 14 Competition Landscape 
   14.1 Mumps Vaccine Market: Competitive Dashboard
   14.2 Global Mumps Vaccine Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Merck & Co. Inc.
      14.3.2 MedImmune
      14.3.3 Astellas Pharma India Private Limited
      14.3.4 Sanofi
      14.3.5 Emergent BioSolutions Inc.
      14.3.6 GlaxoSmithKline plc.
      14.3.7 Bavarian Nordic
      14.3.8 Johnson & Johnson Private Limited
      14.3.9 Serum Institute of India Pvt. Ltd.
      14.3.10 CSL Limited
Segments Covered in the Report
The global Mumps Vaccine market has been segmented based on

By Age Group
  • Adult
  • Pediatric
By Distribution Channel
  • Retail Pharmacies
  • Hospitals Pharmacies
  • Drug Stores
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Merck & Co. Inc.
  • MedImmune
  • Astellas Pharma India Private Limited
  • Sanofi
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc.
  • Bavarian Nordic
  • Johnson & Johnson Private Limited
  • Serum Institute of India Pvt. Ltd.
  • CSL Limited

Buy Report